Market supply obligations

Publication: pbbr
Author: Rita Roque de Pinho
Date: 11 November 2019

With the publication in Infarmed’s website of the Drug Availability Management Regulation approved by Infarmed’s board of directors, occurred yesterday, the recent revision of the legal framework of medicinal products supply obligations contained in Decree-Law nr. 112/2019 of 16 August (“Decree-Law 112/2019”) that amended the Medicinal Products Legal Act2 , was completed.

Please note, your browser is out of date.
For a good browsing experience we recommend using the latest version of Chrome, Firefox, Safari, Opera or Internet Explorer.